We have studied polypeptide processing by purified protea somes, with regar
d to proteolytic specificity and cytotoxic T-lymphocyte (CTL) epitope gener
ation. Owing to defined preferences with respect to cleavage sites and frag
ment length, proteasomes degrade polypeptide substrates into cohorts of ove
rlapping oligopeptides. Many of the proteolytic fragments exhibit structura
l features in common with major histocompatibility complex (MHC) class I li
gands including fragment size and frequencies of amino acids at fragment bo
undaries. Proteasomes frequently generate definitive MHC class I ligands an
d/or slightly longer peptides, while substantially larger peptides are rare
. Individual CTL epitopes are produced in widely varying amounts, often con
sistent with immunohierarchies among CTL epitopes. We further found that po
lypeptide processing is remarkably conserved among proteasomes of eukaryoti
c origin and that invertebrate proteasomes can efficiently produce known hi
gh-copy MHC class I ligands, suggesting evolutionary adaptation of the tran
sporter associated with antigen processing and MHC class I to ancient const
raints imposed by proteasomal protein degradation.